Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Divarasib
Trade Name
Synonyms GDC-6036|GDC6036|GDC 6036
Drug Descriptions

Divarasib (GDC-6036) is a selective inhibitor of KRAS G12C that blocks downstream signaling, and may lead to anti-tumor activity (PMID: 37611121).

DrugClasses KRAS G12C inhibitor 32
CAS Registry Number 2417987-45-0
NCIT ID C173995


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Divarasib Atezolizumab Divarasib 0 1
Bevacizumab + Divarasib Bevacizumab Divarasib 0 1
Cetuximab + Divarasib Cetuximab Divarasib 0 1
Divarasib Divarasib 0 1
Divarasib + Erlotinib Divarasib Erlotinib 0 1
Divarasib + Pembrolizumab Divarasib Pembrolizumab 0 1
Divarasib + RLY-1971 Divarasib RLY-1971 0 0

Additional content available in CKB BOOST